Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent

Surgery

Volumn 144, Issue 2, 2008, Pages 245-251

  Roztocil, Elisa ^a   Nicholl, Suzanne M ^a   Davies, Mark G ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ADAM PROTEIN; AMINOCAPROIC ACID; ANTIBODY; APROTININ; DIPHTHERIA TOXOID CRM197; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR ANTIBODY; HEPARIN BINDING EPIDERMAL GROWTH FACTOR INHIBITORY ANTIBODY; ILOMASTAT; INSULIN; PROTEINASE INHIBITOR; TAPI 0; TAPI 1;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VASCULAR SMOOTH MUSCLE;

ADAM PROTEINS; CELL MOVEMENT; CELLS, CULTURED; CORONARY VESSELS; DIPEPTIDES; HUMANS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 1; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PLASMIN; PLATELET-DERIVED GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASES; RECEPTOR CROSS-TALK; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SOMATOMEDINS; TYRPHOSTINS;

EID: 47549086108     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.03.023     Document Type: Article

References (37)

1. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
2. Olijhoek J.K., VanderGraaf Y., Banga J.D., Algra A., Rabelink T.J., and Visseren F.L. Second Manifestation of Arterial Disease SMART study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 173 (2004) 363-369
3. Cheatham B., and Kahn C.R. Insulin action and the insulin signaling network. Endocr Rev 16 (1995) 117-142
4. Hackel P.O., Zwick E., Prenzel N., and Ullrich A. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11 (1999) 184-189
5. Lyu J., Lee K.S., and Joo C.K. Transactivation of EGFR mediates insulin-stimulated ERK1/2 activation and enhanced cell migration in human corneal epithelial cells. Mol Vis 12 (2006) 1403-1410
6. Nicholl S.M., Roztocil E., and Davies M.G. Urokinase (uPA) induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. J Vasc Surg 41 (2005) 672-681
7. Tanski W.J., Fegley A.J., Roztocil E., and Davies M.G. Domain dependent actions of urokinase on smooth muscle cell responses. J Vasc Surg 39 (2004) 214-222
8. Tanski W.J., Nicholl S.M., Kim D., Fegley A.J., Roztocil E., and Davies M.G. Sphingosine-1-phosphate-induced smooth muscle cell migration involves the mammalian target of rapamycin. J Vasc Surg 39 (2005) 91-98
9. Zhang S., Yang Y., Kone B.C., Allen J.C., and Kahn A.M. Insulin-stimulated cyclic GMP inhibits vascular smooth muscle cell migration by inhibiting Ca/calmodulin-dependent protein kinase II. Circulation 107 (2003) 1539-1544
10. Yang M., Foster E., and Kahn A.M. Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells. Am J Hypertens 18 (2005) 1329-1334
11. Jacob A., Molkentin J.D., Smolenski A., Lohmann S.M., and Begum N.I. Insulin inhibits PDGF-directed VSMC migration via NO/cGMP increase of MKP-1 and its inactivation of MAPKs. Am J Physiol 283 (2002) C704-C713
12. Wang C.C.L., Gurevich I., and Draznin B. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes 52 (2003) 2562-2569
13. 2 levels: essential role of cGMP. Am J Physiol 286 (2004) H2103-H2112
14. Myers M.G.J., Backer J.M., Sun X.J., Shoelson S., Hu P., Schlessinger J., et al. IRS-1 activates phosphatidylinositol 3-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci U S A 89 (1992) 10350-10354
15. Burgering B.M., and Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 76 (1995) 599-602
16. Ray L.B., and Sturgill T.W. Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro. Proc Natl Acad Sci U S A 84 (1987) 1502-1506
17. Sasaoka T., Rose D.W., Jhun B.H., Saltiel A.R., Draznin B., and Olefsky J.M. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem 269 (1994) 13689-13694
18. Jiang Z.Y., Lin Y.-W., Clemont A., Feener E.P., Hein K.D., Igarashi M., et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 104 (1999) 447-457
19. Cus K., Maezono K., Osman A., Pendergrass M., Patti M.E., Pratipanawatr T., et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105 (2000) 311-320
20. Montagnani M., Golovchenko I., Kim I., Koh G.Y., Goalstone M.L., Mundhekar A.N., et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 277 (2002) 1794-1799
21. Carpenter G. EGF receptor transactivation mediated by the proteolytic production of EGF-like agonists. Sci STKE 15 (2000) PE1
22. Pastore C.J., Isner J.M., Bacha P.A., Kearney M., and Pickering J.G. Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivo: results of local versus systemic administration. Circ Res 77 (1995) 519-529
23. Chan A.K., Kalmes A., Hawkins S., Daum G., and Clowes A.W. Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery. J Vasc Surg 37 (2003) 644-649
24. Raab G., and Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333 (1997) F179-F199
25. Bresner G.E., Whelton D., Crissman-Combs M.A., Steffen C.L., Kim G.Y., and Brigstock D.R. Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase or synthetic heparin-binding HB-EGF fragments. Growth Factors 7 (1992) 289-296
26. Nakata A., Miyagawa J., Yamashita S., Nishida M., Tamura R., Yamamori K., et al. Localization of heparin binding growth factor-like growth factor in human coronary arteries: possible roles of HB-EGF in the formation of coronary atherosclerosis. Circulation 994 (1996) 2778-2786
27. Reape T.J., Wilson V.J., Kanczler J.M., Ward J.P., Burnard K.G., and Thomas C.R. Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue. J Mol Cell Cardiol 29 (1997) 1639-1648
28. Igura T., Kawata S., Miyagawa J., Inui Y., Tamura S., Fukuda K., et al. Expression of HB-EGF-like growth factor in neointimal cells induced by balloon injury in rat carotid arteries. Arterioscler Thromb Vasc Biol 16 (1996) 1524-1531
29. Wetzker R., and Bohmer F.D. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 4 (2003) 651-657
30. Pierce K.L., Tohgo A., Ahn S., Field M.E., Luttrell L.M., and Lefkowitz R.J. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J Biol Chem 276 (2001) 23155-23160
31. Suzuki H., Sunayama S., Kawal S., Okada R., Yamaguchi H., Aizawa T., et al. ECM remodelling in restenotic human coronary atherosclerotic plaque of balloon angioplasty. J Am Coll Cardiol 29 (1997) 421A
32. Nanba D., and Higashiyama S. Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor. Cytokine Growth Factor Rev 15 (2004) 13-19
33. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8 (2002) 35-40
34. Yang M., Yang Y., Zhang S., and Kahn A.M. Insulin-stimulated hydrogen peroxide increases guanylate cyclase activity in vascular smooth muscle. Hypertension 42 (2003) 569-573
35. Sundaresan M., Yu Z.X., Ferrans V.J., Irani K., and Finkel T. Requirements for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
36. Weber D.S., Taniyama Y., Rocic P., Seshiah P.N., Dechert M.A., Gerthoffer W.T., et al. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res 94 (2004) 1219-1226
37. Yasunari K., Maeda K., Nakamura M., and Yoshikawa J. Pressure promotes angiotensin II-mediated migration of human coronary smooth muscle cells through increase in oxidative stress. Hypertension 39 (2002) 433-437